Endo-BCN-PEG4-Palmitic

Endo-BCN-PEG4-Palmitic is a PEG derivative containing an endo-BCN cycloalkyne structure, a tetraethylene glycol (PEG4) linker, and a Palmitic acid (HY-N0830) fatty acid group. Endo-BCN-PEG4-Palmitic can be used for drug delivery, surface modification, and click chemistry reactions[1].

Product Specifications

UNSPSC

12352200

Hazard Statement

H302-H315-H319-H335

Target

Biochemical Assay Reagents

Related Pathways

Others

Field of Research

Others

Smiles

[H][C@]12C([C@@H]2COC(NCCOCCOCCOCCOCCNC(CCCCCCCCCCCCCCC)=O)=O)([H])CCC#CCC1

Molecular Formula

C37H66N2O7

Molecular Weight

650.93

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

References & Citations

[1]Singh SS, et al. Fatty Acid Derivatization and Cyclization of the Immunomodulatory Peptide RP-182 Targeting CD206high Macrophages Improve Antitumor Activity. Mol Cancer Ther. 2024 Dec 3;23 (12) :1827-1841.